Pharmabiz

Longevity healthcare startup Vytalyou raises Rs. 9 crore to expand clinic network

Longevity healthcare startup Vytalyou raises Rs. 9 crore to expand clinic network: Our Bureau, Mumbai Thursday, October 1, 2026, 13:30 Hrs [IST] Vytalyou, a doctor-led longevity a ...
Pharmabiz

Shilpa Biologicals launches SB HiMax platform at CPHI Milan

Shilpa Biologicals, a subsidiary of Shilpa Medicare , launches its new gene to GMP manufacturing platform, SB HiMax which ...
Pharmabiz

DBV Technologies submits BLA to US FDA for Viaskin peanut patch in children aged 4 to 7 tears

DBV Technologies submits BLA to US FDA for Viaskin peanut patch in children aged 4 to 7 tears: Châtillon, France Thursday, October 1, 2026, 18:00 Hrs [IST] DBV Technologies, a la ...
Pharmabiz

Merck’s tulisokibart meets primary and key secondary endpoints in phase 2b study in patients with moderate to severe hidradenitis suppurativa

Merck’s tulisokibart meets primary and key secondary endpoints in phase 2b study in patients with moderate to severe hidradenitis suppurativa: Rahway, New Jersey Thursday, Octob ...
Pharmabiz

Acrotech Biopharma launches Adquey in US

Acrotech Biopharma Inc., a biopharmaceutical company focused on developing and commercializing innovative proprietary medicines, announced the US launch of Adquey (difamilast 1%) ointment, a ...
Pharmabiz

Cytrellis Biosystems partners with KoreAx Company for commercialization of ellacor micro-coring technology in South Korea

Cytrellis Biosystems partners with KoreAx Company for commercialization of ellacor micro-coring technology in South Korea: Woburn, Massachusetts Thursday, October 1, 2026, 12:00 H ...
Pharmabiz

Baby Memorial Hospital Vadakara enters Asia and India Book of Records on World Heart Day

Baby Memorial Hospital Vadakara enters Asia and India Book of Records on World Heart Day: Our Bureau, Mumbai Thursday, October 1, 2026, 14:50 Hrs [IST] Baby Memorial Hospital (BMH ...
Pharmabiz

Piramal Pharma Solutions and NP2 to complete cyclophosphamide development phase in October

Piramal Pharma Solutions and NP2 to complete cyclophosphamide development phase in October: Our Bureau, Mumbai Thursday, October 1, 2026, 14:30 Hrs [IST] Piramal Pharma Solutions, ...
Pharmabiz

Takeda announces positive data from three phase 3 LATITUDE psoriasis studies of zasocitinib in adults with moderate-to-severe plaque psoriasis

Takeda announces positive data from three phase 3 LATITUDE psoriasis studies of zasocitinib in adults with moderate-to-severe plaque psoriasis: Osaka, Japan Thursday, October 1, 2 ...
Pharmabiz

Truevis Technologies and Neusoft to strengthen Pan-India medical imaging support

Truevis Technologies and Neusoft to strengthen Pan-India medical imaging support: Our Bureau, Mumbai Thursday, October 1, 2026, 15:45 Hrs [IST] Truevis Technologies Pvt. Ltd., in ...
Pharmabiz

India hosts WCOG 2026 with focus on changing Global GI disease burden

India hosts WCOG 2026 with focus on changing Global GI disease burden: Our Bureau, Mumbai Thursday, October 1, 2026, 13:50 Hrs [IST] The World Congress of Gastroenterology (WCOG) ...
Pharmabiz

Boehringer Ingelheim investments into sustainability-related programmes and health partnerships to reach EUR 500 million

Boehringer Ingelheim announced that it projects its investments into sustainability-related programmes and health partnerships that aim to help improve the lives of people, animals and their ...